Case Overview
Wegovy® is an injectable weight-loss drug used to help overweight and obese adults with weight management. It has recently gained public attention due to shortages, off-label use and serious side effects. If you or a loved one has been harmed by the drug, you may be eligible to file a Wegovy lawsuit.
What is Wegovy?
Wegovy is part of the drug class semaglutide. It is an injectable medication that the FDA-approved for weight loss. Novo Nordisk developed semaglutide drugs to manage diabetes and obesity. They work by regulating insulin release and mimicking natural hormones that give the feeling of being full after eating a meal. These are called satiety hormones. Glucagon-like peptide 1 (GLP-1) is a satiety hormone.
Wegovy is a GLP-1 receptor agonist (GLP-1 RA), which means it mimics the natural GLP-1 hormone. Other GLP-1 RA medications include semaglutide drugs like Ozempic® and Rybelsus®. Wegovy was developed after diabetes drug testing found semaglutide drugs caused weight loss. Wegovy is a higher dosage version of the diabetes drug Ozempic.
The drug’s FDA approved label indicates usage for chronic weight management for overweight or obese adults with at least one weight-related condition. Weight-related conditions include high blood pressure, Type 2 diabetes and high cholesterol. The approval also indicates that Wegovy should be used in conjunction with lifestyle changes like reduced caloric intake and increased exercise.
Wegovy differs from other semaglutide drugs in its dosage and approved treatable conditions.
Delivery: | Injectable | Injectable |
Dosage: | Begin at 0.25 mg weekly for 4 weeks. Increase dosage every week to 0.5 mg after 4 weeks. Doctors may authorize dosage increases to 2 mg weekly if needed. | Begin at 0.25 mg weekly for 4 weeks. Increase dosage every 4 weeks until total weekly dosage of 2.4 mg is reached. |
Approved For: | Type 2 diabetes | Chronic weight management |
What are the Wegovy lawsuits about?
People are filing Wegovy lawsuits after experiencing serious and unexpected side effects that they believe were caused by the drug. For example, in September 2023, a Pennsylvania woman represented by Motley Rice filed a lawsuit against the drug’s manufacturer, Novo Nordisk.
The lawsuit details our client’s severe gastrointestinal issues and subsequent hospitalization for gastroparesis after taking Wegovy. This lawsuit addresses two main claims with Wegovy and its manufacturer, Novo Nordisk.
- Failure to warn: The Pennsylvania lawsuit alleges that the plaintiff experienced side effects not included on the drug’s warning label.
- Negligent misrepresentation and marketing: The lawsuit also alleges that Novo Nordisk misrepresented the severity of potential side effects and engaged in harmful marketing practices that targeted teens and minorities.
Besides lawsuits filed by people harmed by the drug, Wegovy has also been involved in lawsuits filed by drug maker Novo Nordisk. The drug manufacturer has filed lawsuits against wellness and medical spas, weight loss clinics and compounding pharmacies for selling off-brand versions of Wegovy and Ozempic.
Consumers should be aware of these off-brand versions, which are untested and may come with additional side effects.
If you or a loved one took Wegovy and experienced severe side effects like gastroparesis, you may be eligible to file a lawsuit.
Our law firm has represented and achieved recoveries for plaintiffs in personal injury lawsuits. Compensation through verdicts or settlements can help you pay for medical expenses and give you peace of mind while you recover.
Contact us
If you or a loved one suffered pancreatic cancer, intestinal blockage or stomach paralysis/gastroparesis after taking Ozempic, Wegovy or another GLP-1 Receptor drug for diabetes or weight loss, you may have a claim. Complete this webform or call 1.800.768.4026 to contact attorney Sara Couch for more information or to discuss a potential claim.
1
Submit
Information
Call us or fill out our online form with your case details.
2
Case
Review
Our team meticulously reviews your information to assess your case's potential.
3
Case
Consultation
Discuss next steps with our lawyer for tailored guidance.
Motley Rice LLC is primarily located at 28 Bridgeside Drive, Mt. Pleasant, SC 29464. The attorneys responsible for this advertising are Donald A. Migliori (MA, MN, NY, RI, SC), Nathan D. Finch (DC, VA), Esther Berezofsky (NJ, PA), Kimberly Barone Baden (CA), P. Graham Maiden (MT, OH), John E. Herrick (MD), John D. Hurst (NC, WV), Jennifer G. Guy (AZ), Kevin R. Dean (GA), Jonathan D. Orent (WI), and Louis M. Bograd (KY).
LEGAL SERVICES IN KENTUCKY MAY BE PERFORMED BY OTHER MOTLEY RICE ATTORNEYS.
Motley Rice LLC, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through Motley Rice New Jersey LLC. Esther Berezofsky attorney responsible for New Jersey practice. Results may vary depending on your particular facts and legal circumstances.
Motley Rice LLP, a CA limited liability partnership, conducts the Firm’s CA practice.
Results depend on the case facts and will differ if based on different facts.
Each case is different. Our past record is no assurance that we successfully reach a favorable result in any future case.
The choice of a lawyer is an important decision and should not be based solely upon advertisements. Past results afford no guarantee of future results. Every case is different and must be judged on its own merits.
Past results afford no guarantee of future results. Every case is different and must be judged on its own merits.
Prior results do not guarantee a similar outcome, cases we mention are illustrative of the matters we handle, case results depend on a variety of factors unique to each case; and we have not provided the results of all of our cases.